Hong Kong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
The archive
Page 6 of 170 of this archive, newest first.
The mechanism behind the mechanism
The clinical effect profile is almost fully predictable from where the receptor is expressed, which is unusual and useful.
A purity figure is a numerator over a denominator, and both are choices
Regulated pharmaceutical practice has explicit reporting, identification and qualification thresholds. This trade has none, which is why a purity figure carries no…
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 29-day notice: how a compounding wind-down works in Mexico
The document is four pages. Three of them are about dates.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 37% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Six words a verification badge would need to mean anything
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
Side effects, cost, supply, target: four reasons with four trajectories
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
A shortage listing ends. 24 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Suzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Singapore declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
GIP was a failed target for thirty years. Then it was not.
What adding GIP activity does, on the current evidence, and what remains unresolved.
Steady state is not a metaphor — it is an arithmetic fact about exenatide
What the pharmacokinetic data supports about dose timing, missed doses and interruption.
The tolerability data everybody quotes and nobody reads
Trial adverse-event tables count episodes reported to a study nurse. They are the best data we have and they systematically under-record the mundane.
From the floor in Tianjin: 20 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Mexico guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What a 15% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
Germany caps liraglutide prescribing to 10 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The retest date and the expiry date are not the same document
We asked twenty companies three questions about stability data and print every answer, refusal and non-response.
France declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The relabeller trading as Vantris Bio closes after 5 years
A proper account of an operation that existed, and of what closing it cost.
What the new the United Kingdom guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What twenty companies say about storage, and what they have measured
A stability programme needs a protocol, defined conditions, a stability-indicating method and time. Time is the ingredient no commercial testing service can sell.
Side effects, cost, supply, target: four reasons with four trajectories
The trials studied planned withdrawal. Almost nobody stops that way.
Ireland caps exenatide prescribing to 3 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
Denmark pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Guangzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.